Corticomedullary Differentiation in Fetal Kidneys: A Necessary Evil?

Abstract

Renal corticomedullary differentiation (CMD) is a crucial indicator of fetal renal health and is detectable as early as 15 to 16 weeks of gestation. Abnormalities in CMD, such as accentuation or loss, may signal underlying renal diseases. CMD assessment via prenatal ultrasound evolves dynamically throughout gestation, reflecting changes in cortical echogenicity and cystic structures. While CMD alterations can indicate conditions like glomerulonephritis or obstructive uropathies, they also offer prognostic insights into future renal function. This case report highlights the importance of early detection and comprehensive evaluation of CMD for optimising prenatal renal care.

Keywords

corticomedullary differentiation - fetal kidneys - GFR - loss - NCCT - (PET)-SPECT - indicator - prenatal diagnosis

Publikationsverlauf

Artikel online veröffentlicht:
22. Juli 2024

• References

• 1 Chaumoitre K, Brun M, Cassart M. et al. Differential diagnosis of fetal hyperechogenic cystic kidneys unrelated to renal tract anomalies: a multicenter study. Ultrasound Obstet Gynecol 2006; 28 (07) 911-917
• 2 Avni FE, Garel C, Cassart M, D'Haene N, Hall M, Riccabona M. Imaging and classification of congenital cystic renal diseases. AJR Am J Roentgenol 2012; 198 (05) 1004-1013
• 3 Semelka RC, Corrigan K, Ascher SM, Brown JJ, Colindres RE. Renal corticomedullary differentiation: observation in patients with differing serum creatinine levels. Radiology 1994; 190 (01) 149-152
• 4 Kettritz U, Semelka RC, Brown ED, Sharp TJ, Lawing WL, Colindres RE. MR findings in diffuse renal parenchymal disease. J Magn Reson Imaging 1996; 6 (01) 136-144
• 5 Chung JJ, Semelka RC, Martin DR. Acute renal failure: common occurrence of preservation of corticomedullary differentiation on MR images. Magn Reson Imaging 2001; 19 (06) 789-793
• 6 Glass RB, Astrin KH, Norton KI. et al. Fabry disease: renal sonographic and magnetic resonance imaging findings in affected males and carrier females with the classic and cardiac variant phenotypes. J Comput Assist Tomogr 2004; 28 (02) 158-168
• 7 Lee VS, Kaur M, Bokacheva L. et al. What causes diminished corticomedullary differentiation in renal insufficiency?. J Magn Reson Imaging 2007; 25 (04) 790-795
• 8 Duel BP, Mogbo K, Barthold JS, Gonzalez R. Prognostic value of initial renal ultrasound in patients with posterior urethral valves. J Urol 1998; 160 (3 Pt 2): 1198-1200 , discussion 1216
• 9 Carr MC, Benacerraf BR, Estroff JA, Mandell J. Prenatally diagnosed bilateral hyperechoic kidneys with normal amniotic fluid: postnatal outcome. J Urol 1995; 153 (02) 442-444
• 10 Estroff JA, Mandell J, Benacerraf BR. Increased renal parenchymal echogenicity in the fetus: importance and clinical outcome. Radiology 1991; 181 (01) 135-139
• 11 Tsatsaris V, Gagnadoux MF, Aubry MC, Gubler MC, Dumez Y, Dommergues M. Prenatal diagnosis of bilateral isolated fetal hyperechogenic kidneys. Is it possible to predict long term outcome?. BJOG 2002; 109 (12) 1388-1393
• 12 Surányi A, Retz C, Rigo J, Schaaps JP, Foidart JM. Fetal renal hyperechogenicity in intrauterine growth retardation: importance and outcome. Pediatr Nephrol 2001; 16 (07) 575-580
• 13 Piepsz A, Tondeur M, Ham H. Revisiting normal (51)Cr-ethylenediaminetetraacetic acid clearance values in children. Eur J Nucl Med Mol Imaging 2006; 33 (12) 1477-1482
• 14 Schwartz GJ, Furth SL. Glomerular filtration rate measurement and estimation in chronic kidney disease. Pediatr Nephrol 2007; 22 (11) 1839-1848
• 15 Bratton VS, Ellis EN, Seibert JT. Ultrasonographic findings in congenital nephrotic syndrome. Pediatr Nephrol 1990; 4 (05) 515-516
• 16 Feitz WFJ, Cornellissen EAM, Blickman JG. Renal disease and renal failure. In: Carty H, Brunelle F, Stringer DA. et al, eds. Imaging Children. 2nd ed. Vol. 1. Edinburgh-London-New York-Oxford-Philadelphia-St. Louis-Sydney-Toronto: Elsevier; 2005: 617-642
• 17 Gordon I, Riccabona M. Investigating the newborn kidney: update on imaging techniques. Semin Neonatol 2003; 8 (04) 269-278
• 18 Riccabona M, Ring E. Renal agenesis, dysplasia, hypoplasia and cystic diseases of the kidney. In: Fotter R. ed. Pediatric Uroradiology. Berlin-Heidelberg-New York: Springer; 2001: 229-252
• 19 Riccabona M, Mache CJ, Dell'Aqua A. et al. Renal parenchymal disease. In: Fotter R. ed. Pediatric Uroradiology. Berlin-Heidelberg-New York: Springer; 2001: 253-280
• 20 Ring E, Fotter R. The newborn with oligoanuria. In: Fotter R. ed. Pediatric Uroradiology. Berlin-Heidelberg-New York: Springer; 2001: 313-320
• 21 Salame H, Damry N, Vandenhoudt K, Hall M, Avni FE. The contribution of ultrasound for the differential diagnosis of congenital and infantile nephrotic syndrome. Eur Radiol 2003; 13 (12) 2674-2679
• 22 Garel L, Habib R, Babin C, Lallemand D, Sauvegrain J, Broyer M. Hemolytic-uremic syndrome. Diagnostic and prognostic value of ultrasound. Ann Radiol (Paris) 1983; 26 (2-3): 169-174
• 23 Patriquin HB, O'Regan S, Robitaille P, Paltiel H. Hemolytic-uremic syndrome: intrarenal arterial Doppler patterns as a useful guide to therapy. Radiology 1989; 172 (03) 625-628
• 24 Peruzzi L, Gianoglio B, Porcellini MG, Coppo R. Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic. Lancet 1999; 354 (9190): 1615
• 25 Holmes RP, Stone PR. Severe oligohydramnios induced by cyclooxygenase-2 inhibitor nimesulide. Obstet Gynecol 2000; 96 (5 Pt 2): 810-811
• 26 Cuzzolin L, Dal Cerè M, Fanos V. NSAID-induced nephrotoxicity from the fetus to the child. Drug Saf 2001; 24 (01) 9-18
• 27 Smaoui H, Mallie JP, Cheignon M, Borot C, Schaeverbeke J. Glomerular alterations in rat neonates after transplacental exposure to gentamicin. Nephron J 1991; 59 (04) 626-631
• 28 Nathanson S, Moreau E, Merlet-Benichou C, Gilbert T. In utero and in vitro exposure to beta-lactams impair kidney development in the rat. J Am Soc Nephrol 2000; 11 (05) 874-884
• 29 Levey AS, de Jong PE, Coresh J. et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011; 80 (01) 17-28